Cat. No. | Product Name | Field of Application | Chemical Structure |
---|---|---|---|
DC8775 | LED209 |
LED209 is a potent QseC inhibitor that blocks both norepinephrine- and epinephrine-triggered QseC-dependent virulence gene expression at 5 pM in vitro.
More description
|
![]() |
DC10934 | JBJ-16-111 |
JBJ-16-111 is a small molecule that inhibits dengue virus (DENV) by binding to its envelope protein E..
More description
|
![]() |
DCAPI1366 | Itraconazole (Sporanox) |
Itraconazole (Sporanox)
More description
|
![]() |
DC11494 | INX-08189 |
INX-08189 is a phosphoramidate prodrug of O-6-methyl-2-C-methyl guanosine, potent inhibitor of HCV NS5B polymerase with IC50 of 10 nM in replicon assay.
More description
|
![]() |
DC9472 | HIV-1 integrase inhibitor 2 |
HIV-1 integrase inhibitor, in the treatment of human immunodeficiency virus (HIV) infection.
More description
|
![]() |
DC9473 | HIV-1 integrase inhibitor |
HIV-1 integrase inhibitor ((Z)-4-(3-(azidomethyl)phenyl)-2-hydroxy-4-oxobut-2-enoic acid) is uesful for anti-HIV.
More description
|
![]() |
DC11297 | GS-9822 |
GS-9822 is a novel, potent NCINI with a higher barrier to resistance relative to early prototype NCINIs, including GS-9695.
More description
|
![]() |
DC8893 | Garenoxacin Mesylate hydrate |
Garenoxacin mesylate hydrate is a novel oral des-fluoro(6) quinolone with potent antimicrobial activity, against common respiratory pathogens, including resistant strains.
More description
|
![]() |
DC8929 | Garenoxacin |
Garenoxacin is a quinolone antibiotic for the treatment of Gram-positive and Gram-negative bacterial infections.
More description
|
![]() |
DC7824 | Fosfluconazole(INN) |
Fosfluconazole (INN) is a water-soluble phosphate prodrug of fluconazole
More description
|
![]() |
DC8047 | VRT-1353385 |
For the detailed information of VRT-1353385, the solubility of VRT-1353385 in water, the solubility of VRT-1353385 in DMSO, the solubility of VRT-1353385 in PBS buffer, the animal experiment (test) of VRT-1353385, the cell expriment (test) of VRT-1353385, the in vivo, in vitro and clinical trial test of VRT-1353385, the EC50, IC50,and affinity,of VRT-1353385, For the detailed information of VRT-1353385, the solubility of VRT-1353385 in water, the solubility of VRT-1353385 in DMSO, the solubility of VRT-1353385 in PBS buffer, the animal experiment (test) of VRT-1353385, the cell expriment (test) of VRT-1353385, the in vivo, in vitro and clinical trial test of VRT-1353385, the EC50, IC50,and affinity,of VRT-1353385, Please contact DC Chemicals..
More description
|
![]() |
DC9350 | Faropenem daloxate |
Faropenem daloxate is the first oral penem in a new class of beta-lactam antibiotics.
More description
|
![]() |
DCAPI1011 | Famciclovir (Famvir) |
Famciclovir (Famvir)
More description
|
![]() |
DC4234 | Etravirine |
Etravirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI) of human immunodeficiency virus type 1 (HIV-1).
More description
|
![]() |
DCAPI1479 | Efavirenz |
Efavirenz is a nonnucleoside HIV-1 reverse transcriptase (RT) inhibitor which selectively inhibits the glucuronidation of 3'-Azido-3'-deoxythymidine β-D-glucuronide, Sodium Salt. Studies suggest that Efavirenz binds to a distinct site of reverse transcrip
More description
|
![]() |
DC8897 | Delavirdine |
Delavirdine(U 90152) is a potent non-nucleoside reverse transcriptase inhibitor (NNRTI).
More description
|
![]() |
DC11352 | Delavirdine (mesylate) |
Delavirdine is a non-nucleoside reverse transcriptase inhibitor (NNRTI) that selectively inhibits HIV-1 reverse transcriptase over DNA polymerase α and δ in vitro (IC50s = 0.26, 440, and >550 μM, respectively).
More description
|
![]() |
DC11232 | D715-2441 |
D715-2441 (D 715-2441) is a novel antiviral compound that interferes with the conserved cap-binding domain of the PB2 protein, exhibits potent antiviral activity against influenza A viruses (IAVs) with IC50 of 1.7-4.4 uM.
More description
|
![]() |
DC11214 | Cyclophilin inhibitor C31 |
Cyclophilin inhibitor C31 (SMCypI C31) is a small-molecule cyclophilin (CypA) inhibitor (SMCypI) with PPIase inhibition IC50 of 0.1 uM, displays anti-HCV activity (HCV Gt1b replicon EC50=0.4 uM) and disrupts the CypA-NS5A interaction.
More description
|
![]() |
DC10933 | Compound 3-110-22 |
Compound 3-110-22 is a small molecule that inhibits dengue virus (DENV) by binding to its envelope protein E.
More description
|
![]() |
DC11081 | Coblopasvir |
Coblopasvir (KW136, KW-136) is a novel HCV NS5A inhibitor under development for treatment of HCV infection..
More description
|
![]() |
DC11061 | ClpP inhibitor M21 |
ClpP inhibitor M21 is a noncompetitive inhibitor of ClpP with IC50 of 41.42 uM, inhibits ClpP cleavage of SUc-LY-AMC substrate in a peptidase assay.
More description
|
![]() |
DC8937 | Clarithromycin |
Clarithromycin is a macrolide antibiotic and a CYP3A4 inhibitor.
More description
|
![]() |
DCAPI1024 | Cefditoren pivoxil |
Cefditoren pivoxil
More description
|
![]() |
DC9360 | Buparvaquone |
Buparvaquone(Butalex) is a hydroxynaphthoquinone antiprotozoal drug related to parvaquone and atovaquone; it is a promising compound for the therapy and prophylaxis of all forms of theileriosis.
More description
|
![]() |
DC7007 | BMS-538203 |
BMS-538203 is a highly efficient HIV integrase inhibitor and antiviral agent.
More description
|
![]() |
DC10393 | Bicyclomycin benzoate |
Bicyclomycin benzoate is an antibiotic exhibiting activity against a broad spectrum of Gram-negative bacteria and against the Gram-positive bacterium.
More description
|
![]() |
DC10294 | Bay 41-4109 |
BAY 41-4109 is a potent inhibitor of human hepatitis B virus (HBV) with an IC50 of 53 nM.
More description
|
![]() |
DCAPI1362 | Azithromycin (Zithromax) |
Azithromycin (Zithromax)
More description
|
![]() |
DC9480 | Atazanavir (sulfate) |
Atazanavir sulfate is a sulfate salt form of atazanavir that is an highly potent HIV-1 protease inhibitor.
More description
|
![]() |